Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Catheter Precision (VTAK) Operating Expenses (2017 - 2025)

Catheter Precision (VTAK) has disclosed Operating Expenses for 9 consecutive years, with $3.2 million as the latest value for Q3 2025.

  • On a quarterly basis, Operating Expenses rose 9.64% to $3.2 million in Q3 2025 year-over-year; TTM through Sep 2025 was $15.0 million, a 34.61% increase, with the full-year FY2024 number at $11.6 million, down 85.2% from a year prior.
  • Operating Expenses was $3.2 million for Q3 2025 at Catheter Precision, down from $4.9 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $66.6 million in Q1 2023 to a low of $2.7 million in Q1 2024.
  • A 5-year average of $8.3 million and a median of $4.9 million in 2025 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: soared 1128.71% in 2023, then crashed 95.95% in 2024.
  • Catheter Precision's Operating Expenses stood at $7.9 million in 2021, then grew by 3.7% to $8.2 million in 2022, then plummeted by 66.91% to $2.7 million in 2023, then grew by 17.33% to $3.2 million in 2024, then rose by 1.25% to $3.2 million in 2025.
  • Per Business Quant, the three most recent readings for VTAK's Operating Expenses are $3.2 million (Q3 2025), $4.9 million (Q2 2025), and $3.7 million (Q1 2025).